Physician profile
Stuart N Graham
NPI 1083680060
$812.84
in general payments reported to CMS, 2019-2025
15 companies · $245 in 2025
The $245 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.86 · 2020: $51.63 · 2022: $64.15 · 2023: $256 · 2024: $107 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $133.18 | 2022-2025 | Doc Band |
| Kaleo, INC. | $104.06 | 2019-2024 | Auvi-Q |
| Phadia US INC. | $99.37 | 2020-2025 | Immunocap |
| Glaxosmithkline, LLC. | $89.74 | 2019-2025 | Bexsero, Arexvy, Shingrix |
| Sobi, INC | $80.09 | 2020-2023 | |
| Sanofi Pasteur INC. | $70.28 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $61.74 | 2024-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Acadia Pharmaceuticals INC | $29.36 | 2023 | Nuplazid |
| Pfizer INC. | $28.83 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $21.60 | 2025 | Neffy |
| Amgen INC. | $20.77 | 2023 | Prolia, Evenity |
| Abbvie INC. | $20.01 | 2023 | |
| Cipher Pharmaceuticals US LLC | $19.59 | 2025 | Natroba, Spinosad |
| Sanofi-Aventis U.S. LLC | $19.57 | 2025 | |
| Therapeuticsmd, INC. | $14.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.